跳至主要内容
临床试验/NCT00100113
NCT00100113Unknown1 期

Study of Interactions Between GBR 12909 and Cocaine

National Institute on Drug Abuse (NIDA)2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2004年6月最近更新:
适应症
相关药物

试验速览

阶段
1 期
入组人数
24
试验地点
2
主要终点
Heart rate

研究概览

简要总结

The purpose of this study is to assess potential interactions between intravenous (IV) cocaine and 3 doses of GBR 12909.

详细描述

This is Phase 1, double-blind, placebo-controlled human laboratory clinical pharmacology study that will assess the potential interactions between IV cocaine and 3 escalating oral doses of GBR 12909. The primary objective is to determine safety of GBR 12909 administration and if there are significant interactions between GBR 12909 treatment concurrent with IV cocaine infusions.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Must be within 20% ideal body weight and must weigh at least 45 kg.
  • Must understand the study procedures and provide written informed consent.
  • Must meet DSM-4 criteria and are non-treatment seeking at time of study.

排除标准

  • Please contact study site for more information

结局指标

主要结局

Heart rate

次要结局

未报告次要终点

研究者

申办方类型
Nih

研究点 (2)

Loading locations...

相似试验